Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Unique substrate recognition by botulinum neurotoxins serotypes A and E.

Sheng Chen1, Joseph T Barbieri

  • 1Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.

The Journal of Biological Chemistry
|February 16, 2006
PubMed
Summary

Botulinum neurotoxins (BoNTs) are zinc proteases that cause paralysis by cleaving SNARE proteins. This study identifies specific SNAP25 regions crucial for BoNT/A and BoNT/E cleavage, aiding inhibitor development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Botulinum neurotoxin Light Chain/A1 uses fast synaptic vesicle cycling to cleave plasma membrane bound SNAP-25.

Communications biology·2025
Same author

Potency Evaluations of Recombinant Botulinum Neurotoxin A1 Mutants Designed to Reduce Toxicity.

International journal of molecular sciences·2024
Same author

Testing a Recombinant Form of Tetanus Toxoid as a Carrier Protein for Glycoconjugate Vaccines.

Vaccines·2023
Same author

Botulinum Neurotoxin A4 Has a 1000-Fold Reduced Potency Due to Three Single Amino Acid Alterations in the Protein Receptor Binding Domain.

International journal of molecular sciences·2023
Same author

How Botulinum Neurotoxin Light Chain A1 Maintains Stable Association with the Intracellular Neuronal Plasma Membrane.

Toxins·2022
Same author

Genetically detoxified tetanus toxin as a vaccine and conjugate carrier protein.

Vaccine·2022

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • Botulinum neurotoxins (BoNTs) are zinc proteases inhibiting neurotransmitter release by cleaving SNARE proteins.
  • Seven BoNT serotypes (A-G) exist, with A and E cleaving SNAP25 at distinct sites.
  • The mechanism of extended substrate recognition and specificity for BoNTs remains unclear.

Purpose of the Study:

  • To elucidate the substrate recognition and cleavage mechanisms of BoNT serotype A and E on SNAP25.
  • To identify specific amino acid residues and domains within SNAP25 critical for BoNT/A and BoNT/E activity.
  • To provide insights for developing targeted small molecule inhibitors against BoNTs.

Main Methods:

  • Saturation mutagenesis and deletion mapping of SNAP25 to determine optimal cleavage domains.

Related Experiment Videos

  • Analysis of substrate recognition sites, including active site (AS) and binding (B) domains.
  • Characterization of specific SNAP25 residues (P1', P3, P5 for LC/A; P1', P2 for LC/E) involved in cleavage.

    • Main Results:

    • Identified residues 156-202 of SNAP25 as the optimal cleavage domain for BoNT/A.
    • Determined a shorter optimal cleavage domain (residues 167-186) for BoNT/E.
    • Resolved distinct sub-sites within these domains, highlighting the roles of specific SNAP25 residues in differential cleavage by BoNT/A and BoNT/E.

    Conclusions:

    • The study clarifies the molecular basis for BoNT/A and BoNT/E substrate specificity on SNAP25.
    • Understanding these cleavage site differences is key to developing selective BoNT inhibitors.
    • These findings pave the way for novel therapeutic strategies targeting neuroparalytic agents.